Zoetis Inc. (ZTS): Price and Financial Metrics
GET POWR RATINGS... FREE!
ZTS POWR Grades
- Quality is the dimension where ZTS ranks best; there it ranks ahead of 94.81% of US stocks.
- The strongest trend for ZTS is in Stability, which has been heading down over the past 31 weeks.
- ZTS ranks lowest in Momentum; there it ranks in the 34th percentile.
ZTS Stock Summary
- With a market capitalization of $88,591,466,407, Zoetis Inc has a greater market value than 97.31% of US stocks.
- ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 371.84 -- higher than 90.27% of US-listed equities with positive expected earnings growth.
- In terms of volatility of its share price, ZTS is more volatile than only 2.21% of stocks we're observing.
- Stocks that are quantitatively similar to ZTS, based on their financial statements, market capitalization, and price volatility, are ANTM, MDLZ, INFY, TJX, and CI.
- ZTS's SEC filings can be seen here. And to visit Zoetis Inc's official web site, go to www.zoetis.com.
ZTS Stock Price Chart Interactive Chart >
ZTS Price/Volume Stats
|Current price||$186.49||52-week high||$187.32|
|Prev. close||$186.60||52-week low||$131.28|
|Day high||$187.00||Avg. volume||1,936,676|
|50-day MA||$174.17||Dividend yield||0.54%|
|200-day MA||$163.88||Market Cap||88.54B|
Zoetis Inc. (ZTS) Company Bio
Zoetis Inc. discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. The company was founded in 1952 and is based in Florham Park, New Jersey.
ZTS Price Forecast Based on DCF Valuation
|Current Price||DCF Fair Value Target:||Forecasted Gain:|
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Zoetis Inc. To summarize, we found that Zoetis Inc ranked in the 30th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Zoetis Inc, consider:
- The company has produced more trailing twelve month cash flow than 81.53% of its sector Healthcare.
- The business' balance sheet suggests that 8% of the company's capital is sourced from debt; this is greater than just 24.53% of the free cash flow producing stocks we're observing.
- ZTS's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 41.08% of tickers in our DCF set.
|Terminal Growth Rate in Free Cash Flow||Return Relative to Current Share Price|
ZTS Latest News Stream
|Loading, please wait...|
ZTS Latest Social Stream
View Full ZTS Social Stream
Latest ZTS News From Around the Web
Below are the latest news stories about Zoetis Inc that investors may wish to consider to help them evaluate ZTS as an investment opportunity.
Latest released the research study on Global Pet Medication Market, offers a detailed overview of the factors influencing the global business scope. Pet Medication Market research report shows the latest market insights with upcoming trends and breakdown of the products
The report titled Global Cat Vitamins Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Cat Vitamins market. The
Dog Vitamins Market Analysis by Emerging Growth Factors and Revenue Forecast to 2027 | Zoetis, Bayer, Zesty Paws
The report titled Global Dog Vitamins Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Dog Vitamins market. The
Anti-worm Medication Market 2021 2027 | Growth Dynamics, Revenue Outlook and Opportunities Forecast | Bayer, Boehringer Ingelheim, Zoetis
The authors of the report have deeply researched key areas of the global Anti-worm Medication market and provided verified market findings and reliable recommendations to help players ensure long-term growth. LOS ANGELES, United States: The global Anti-worm Medication Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical 
No summary available.
ZTS Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|